Doctors working in palliative care see promise in emerging therapies involving psychedelic drugs, but say many questions still need to be addressed.
Articles on Psychedelic treatment
Displaying all articles
Pharmaceutical giants like Johnson & Johnson as well as smaller startups are investing in psychedelic drug development, and both are pursuing FDA approval for their patented psilocybin formulations.
Researchers found a sharp rise in calls to US poison centers about magic mushrooms coincided with their decriminalization in several US cities and states.
Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
The early research suggests the drugs might be effective for some conditions. But scientists have safety concerns.
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of Emergency Medicine and Pediatrics, University of Virginia
-
Professor of Neurology, University of California, San Francisco
-
Researcher of Epidemiology, University of Virginia
-
Honors Faculty Fellow, Associate Teaching Professor, and Associate Director of the Center for Work & Democracy, Arizona State University
-
Associate Professor in Psychological Medicine, University of Auckland, Waipapa Taumata Rau